Modulation of Polymorphonuclear Leukocytes Function by Nitric Oxide

Thrombosis Research

Volumn 100, Issue 3, 2000, Pages 223-247

  Sethi, Sonia ^a   Dikshit, Madhu ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Adhesion; Chemotaxis; Degranulation; Free radical generation; Nitric oxide; NOS inhibitors; Polymorphonuclear leukocytes; Rolling

Indexed keywords

ARGININE; CITRULLINE; CYCLIC GMP; FREE RADICAL; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; OXYHEMOGLOBIN; SUPEROXIDE DISMUTASE;

BIOASSAY; CELL MIGRATION; CYTOKINE PRODUCTION; DEGRANULATION; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; HUMANS; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0034324949     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00320-0     Document Type: Short Survey

References (236)

1. Biosynthesis of nitric oxide from L-Arginine: A pathway for the regulation of cell function and communication
2. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs
3. Calmodulin is a subunit of nitric oxide synthase from macrophages
4. Macrophage nitric oxide synthase subunits-purification, characterization and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme
5. Tetrahydrobiopterin-dependent stabilization of neuronal nitric oxide synthase dimers reduces susceptibility to phosphorylation by protein kinase C in vitro
6. 2+-/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase
7. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
8. Origin of superoxide production by endothelial nitric oxide synthase
9. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
10. Nitric oxide synthase: Aspects concerning structure and catalysis
11. 2+-independent nitric oxide synthase
12. Glucocorticoids do not effect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes
13. Regulation of inducible nitric oxide production by intracellular calcium
14. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells
15. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase
16. Characterization of the L-Arginine nitric oxide pathway in human platelets
17. Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA
18. Human monocytes/ macrophages: NO or no NO?
19. A stable L-Arginine-dependent relaxing factor released from cytokine activated macrophages
20. Isolation of nitric oxide synthase from human platelets
21. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets
22. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators
23. Erythrocytes may synthesize their own nitric oxide
24. Inhibitory effect of unstimulated neutrophils on platelet aggregration by release of a factor similar to endothelium-derived relaxing factor (EDRF)
25. 2+-/Calmodulin dependent isoform in human B and T lymphocytes
26. Exogenous modification of nitrovasodilator-induced cGMP formation in human lymphocytes
27. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation: Role of IFN-gamma in the induction of nitric oxide synthesizing pathway
28. Nitric oxide involvement in tumor-induced immunosuppression
29. The L-Arginine-nitric oxide pathway
30. Interferon-gamma-treated murine macrophages inhibit growth of Tubercle bacilli via the generation of reactive nitrogen intermediates
31. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-Arginine oxidation to nitrite or nitrate
32. L-Arginine- dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes
33. Evaluation of nitrite production by human monocyte-derived macrophages
34. Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages
35. Changes in mechanisms of monocyte/macrophage-mediated cytoxicity during culture: Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing
36. Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes, involvement of the nitric oxide synthase pathway
37. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide
38. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin and nitric oxide-production by blood monocytes and peritoneal macrophages
39. Murine eosinophils and 1L-1:α-1L-1 m RNA detection by in situ hybridization
40. Pharmacological and immunohistochemical evidence for functional nitric oxide synthase in rat peritoneal eosinophils
41. Inflammation, immunoregulation and inducible nitric oxide synthase
42. Vascular endothelial cells synthesize nitric oxide from L-Arginine
43. Human neutrophils and monomuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor
44. Generation of nitric oxide by human neutrophils
45. Decreased production of nitric oxide by human neutrophils during septic multiple organ dysfunction syndrome: Comparison with endotoxin and cytokine effects on normal cells
46. Nitric oxide levels in patients after trauma and during sepsis
47. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock
48. Modulation of nitrogen oxide synthesis in vivo: N(G)-monomethyl-L-Arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage
49. Tissue injury caused by deposition of immune complexes is L-Arg dependent
50. Bacterial infection induces nitric oxide synthase in human neutrophils
51. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat NOS
52. Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia
53. Superoxide and nitric oxide cooperation in hypoxia/Reoxygenation-induced neuron injury
54. Hypoxia potentiates nitric oxide synthase and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells
55. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia
56. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse
57. Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients
58. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: Myeloperoxidase activity assay and histologic verification
59. Role of granulocytes in endothelial injury in coronary heart disease in humans
60. The role of neutrophils in myocardial ischemia and reperfusion
61. Nitric oxide mediated augmentation of polymorphonuclear free radical generation after hypoxia-reoxygenation
62. Pulmonary thromboembolism-induced alterations in nitric oxide release from rat circulating neutrophils
63. Alterations in nitric oxide synthase activity, superoxide anion generation and platelet aggregation in systemic hypertension, and effects of celiprolol
64. Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients
65. Evidence of reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts: A new microbicidal pathway for human polymorphonuclear leukocytes
66. Elevated synovial and serum nitrite suggest increased nitric oxide synthesis in rheumatic diseases
67. Activation of neutrophil reactive oxidant production by synovial fluid from patients with inflammatory joint disease soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells
68. A new relaxing factor in supernatent of incubated rat peritoneal neutrophils
69. Interaction of neutrophils with vascular smooth muscle: Identification of a neutrophil-derived relaxing factor
70. Rat peritoneal neutrophils selectively relax vascular smooth muscles
71. Utologous neutrophil-derived supernatents inhibit endothelium dependent relaxation in human coronary bypass graft
72. Comparative platelet inhibitory effects of human neutrophils and lymphocytes
73. Evidence for the generation of a large amount of nitric oxide-like vascular smooth muscle relaxant by cholesterol-rich neutrophils
74. Inhibition of platelet function by polymorphonuclear leukocytes
75. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro
76. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells
77. Nitric oxide does not contribute to superoxide-mediated sulphydryl oxidation in human polymorphonuclear leukocytes
78. The release of nitric oxide and superoxide anion by neutrophil in-patients with sickle cell anaemia
79. Stimulus-dependent transduction mechanisms for nitric oxide release in human polymorphonuclear neutrophil leukocytes
80. Simultaneous generation of nitric oxide and superoxide by inflammatory cells in rats
81. Rat, mouse and human stimulated by a variety of activating agents produce much less nitrite than rodent macrophages
82. 2 and HOCl
83. 4
84. Conditions to study nitric oxide generation by polymorphonuclear cells from an inflammatory exudate in rats
85. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone
86. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils
87. Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leukocytes
88. Measurement of methemoglobin formation from oxyhemoglobin, a real time continuous assay of nitric oxide release by human polymorphonuclear leukocytes
89. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity
90. Local anaesthetics enhance nitric oxide production by human peripheral neutrophils
91. Nitric oxide synthase in circulating vs extravasated polymorphonuclear leukocytes
92. Biochemical properties of human oral polymorphonuclear leukocytes
93. Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leukocytes
94. Nitrite production by stimulated human polymorphonuclear leukocytes supplemented with azide and catalase
95. Nitrite generation in interlukin -4 treated human macrophage cultures does not involve the nitric oxide synthase pathway
96. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
97. Reactive nitrogen intermediates and antimicrobial activity: Role of nitrite
98. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: A potential additional mechanism of nitric oxide dependent toxicity
99. Purification of nitric oxide synthase from rat macrophages
100. Oxidation of N(G)-hydroxy-L-Arginine to nitric oxide mediated by respiratory burst: An alternative pathway to NO synthesis
101. Nitric oxide generation from extracellularly applied N(G)-hydroxy L- arginine in LPS activated Raw 264 macrophages
102. Co-purification of 130 KD Nitric oxide synthase and a 22 KD link protein from human neutrophils
103. Nitric oxide-generating system as an autocrine mechanism in human polymorphonuclear leukocytes
104. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils
105. Effect of a new non-steroidal antiinflammatory drug, nitrofluribioprofen on the expression of inducible nitric oxide synthase in rat neutrophils
106. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets
107. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets
108. Three regulation mechanisms of nitric oxide synthase
109. Rapid induction of messenger RNA for nitric oxide synthase in rat neutrophils in vivo by endotoxin and its suppression by prednisolone
110. Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide
111. Nitric oxide synthase activity is increased in patients with sepsis syndrome
112. Expression of inducible nitric oxide synthase in circulating neutrophils of the systemic inflammatory response syndrome and septic patients
113. Increased nitric oxide deactivation by polymorphonuclear leukocytes in patients with intermittent claudication
114. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria
115. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils
116. The metabolisin of L-arginine and its significance for EDRF biosynthesis: Cultured endothelial cells recycle L-citrulline to L-Arginine
117. The activation of the arginine-citrulline cycle in macrophages from the spontaneously diabetic BB rats
118. Identification of covalently bound aminoterminal myristic acid in endothelial nitric oxide synthase
119. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages
120. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
121. Macrophage and endothelial cell nitric oxide synthases: Cell-type selective inhibition by N(G)-aminoarginine, N(G)-nitroarginine and N(G)-methyl arginine
122. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank order of potency characteristic of activated macrophages
123. Selective inhibition of constitutive nitric oxide synthase by L-N(G-)nitroarginine
124. Inhibition of purified nitric oxide synthase from rat cerebellum and macrophages by L-Arginine analogues
125. Stimulatory and inhibitory action of nitric oxide donor agents vs nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes
126. Introduction of luminol-dependent chemiluminescence as a method to study silica inflammation in the tissue and phagocytic cells of rat lung
127. Reduction in human neutrophil superoxide anion generation by N-3 polyunsaturated fatty acids: Role of cyclo-oxygenase products and endothelium-derived relaxing factor
128. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence
129. Inhibition of chemotaxis with N(G)-monomethyl-L-Arginine: A role for cyclic GMP
130. In vitro and ex vivo inhibitory effects of L-and D-enantiomers of N(G)-nitro-arginine on endothelium dependent relaxation of rat aorta
131. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain
132. The in vivo unidirectional conversion of Nitro-D-arginine to Nitro-L-Arginine
133. Interaction of nitric oxide synthase inhibitors and their D-enantiomers with rat neutrophil luminol-dependent chemiluminescence response
134. Scavenging of hydroxyl radicals but not of peroxynitrite by inhibitors and substrates of nitric oxide synthases
135. L-Thiocitrulline: A stereospecific, heme-binding inhibitor of nitric oxide synthases
136. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N(G) (1-iminoethyl)-lysine
137. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles
138. N-omega-hydroxy-L-Arginine is an intermediate in the biosynthesis of nitric oxide from L-Arginine
139. The effect of inhibitor diphenyleneiodonium on the superoxide generating system of neutrophils, specific labelling of a component polypeptide of the oxidase
140. Isolation of nitric oxide synthetase,a calmodulin requiring enzyme
141. Isoforms of nitric oxide synthase: Characterization and purification from different cell types
142. Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver
143. Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils
144. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts
145. Feedback inhibition of nitric oxide synthase activity by nitric oxide
146. Spectral characterization of brain and macrophage nitric oxide synthases
147. The transport of cationic amino acids across the plasma membrane of mammalian cells
148. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors
149. Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells
150. Characterization of neuronal amino acid transporters: Uptake of nitric oxide synthase inhibitors and implication for their biological effects
151. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease
152. The microcirculation and inflammation: Modulation of leukocytes-endothelial cell adhesion
153. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
154. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo
155. +T lymphocytes on tumour necrosis factor α-activated vascular endothelium under flow
156. - efflux, which injures endothelial cells by an extracellular mechanism
157. Nitric oxide prevents leukocyte adherence: Role of superoxide
158. Nitric oxide attenuates leukocyte-endothelial interactions via P-selectin in splanchnic ischemia-reperfusion
159. Hydrogen peroxide-induces leukocyte rolling, modulation by endogenous antioxidant mechanisms including nitric oxide
160. Endogenous but not exogenous nitric oxide decreases TNF-α-induced leukocyte rolling
161. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia
162. Platelet-neutrophil interactions: Possible relevance in the pathogenesis of thrombosis and inflammation
163. Ischemeia/reperfusion-induced micro-vascular dysfunction: Role of oxidants and lipid mediators
164. Role of neutrophil-endothelial cell adhesion in inflammatory disorders
165. A novel sialyl Lewisx analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion
166. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion
167. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion
168. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1
169. Rat neutrophils express α4 and β1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1)
170. Nitric oxide: An endogenous modulator of leukocyte adhesion
171. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit
172. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherance to coronary endothelium
173. Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppresion
174. Leukocyte adhesion induced by inhibition of nitric oxide
175. Local L-NAME decreases blood flow and increases leukocyte adhesion via CD-18
176. Nitric oxide modulates microvascular permeability
177. Mediators of leukocyte adhesion in rat mesentric venules elicited by inhibition of nitric oxide synthesis
178. 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis
179. Microvascular responses to inhibition of nitric oxide production: Role of active oxidants
180. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interactions
181. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs
182. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
183. A balance between nitric oxide and oxidants regulates mast cell-dependent-neutrophil-endothelial cell interactions
184. Absence of mast cell involvement in leukocyte adhesion and emigration induced by inhibitor of nitric oxide synthase
185. Nitric oxide donors prevent integrin-induced leukocyte adhesion but not P- selectin dependent rolling, in post ischemia venules
186. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats
187. A proposal for the definition of terms related to locomotion of leukocytes and other cells
188. Shape oscillations: A fundamental response of human neutrophils stimulated by chemotactic peptides
189. Regulation of trans-endothelial neutrophil migration by endogenous Interlukin-8
190. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide
191. L-Arginine inhibits neutrophil adherance and coronary artery dysfunction
192. Nitric oxide donor decreases neutrophil adhesion in both lung and peritoneum during Peritonitis
193. 2 mediated neutrophil adherance to cultured endothelial cells
194. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: Role of P-selectin, ICAM-1 and VCAM-1
195. Inhaled NO prevents IL-1 induced neutrophil accumulation and associated edema in isolated rat lungs
196. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury
197. Modulation of neutrophil migration by exogenous gaseous nitric oxide
198. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro
199. Sodium azide enhances neutrophil migration and exocytosis: Involvement of nitric oxide, cyclic GMP and calcium
200. Nitric oxide, an endothelial cell relaxation factor inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase
201. Exogenous Nitric oxide elicits chemotaxis of neutrophils in vitro
202. Chemotaxis by human neutrophils and cytokineplasts treated with inhibitors of nitric oxide synthase: No suppression of orientation or trajectory
203. Effects of nitric oxide on chemotaxis and endotoxin induced interlukin-8 production in human neutrophils
204. Effect of serotonin carbamylcholine and ascorbic acid on leukocyte cyclic GMP and chemotaxis
205. Cyclic nucleotides regulate the morphological alterations required for chemotaxis in monocytes
206. In vitro stimulation of neutrophil motility by levamisole: Maintenance of cyclic GMP levels in chemotactically stimulated levamisole-treated neutrophils
207. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils
208. Characterization of azurophil and specific granules purified from human polymorphonuclear leukocytes
209. Mechanisms of lysosomal enzyme release from human leukocytes. I. Effect of cyclic nucleotides and colchicine
210. Stimulation of phagocytic release of neutral protease from human neutrophils by cholinergic amines and cyclic 3',5' guanosine monophosphate
211. Reciprocal effects of cAMP and cGMP on microtubule dependent release of lysosomal enzymes
212. Bidirectional regulation of lysosomal enzyme secretion and phagocytosis in human neutrophils by guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate
213. Characteristics of N-formyl-methionyl-leucyl-phenylalanine as an inducer of lysosomal enzyme release from human neutrophils
214. 4 release from human PMN may be mediated by cyclic GMP
215. Cyclic GMP mediated SIN-1-induced inhibition of human polymorphonuclear leukocyte
216. The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leukocyte function in vitro and ex vivo
217. Inhibition by nitric oxide donors of human polymorphonuclear leukocyte function
218. Potentiation and inhibition of fmlp-activated exocytosis in neutrophils by exogenous nitric oxide
219. Regulation of human neutrophil degranulation by LY-83583 and L-Arginine: Role of cGMP-dependent protein kinase
220. 3-Morpholino-Sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: Inhibition of the increase in intracellular free calcium concentrations by N-morpholino-iminoacetonitrite a metabolite of 3-morpholino-sydnonimine
221. The human neutrophil respiratory burst oxidase
222. Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils
223. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes
224. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process
225. Oxygen-dependent inhibition of neutrophil respiratory burst by nitric oxide
226. Nitric oxide-releasing particles inhibit phagocytosis in human neutrophils
227. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human Leukocytes
228. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: Role of nitric oxide
229. Inhibition of nitric oxide synthase by a superoxide generating system
230. Modulation of rat peripheral polymorphonuclear leukocyte response by nitric oxide and arginine
231. Peroxynitrite augments fmlp-stimulated chemilumenescence by neutrophils in human whole blood
232. Enhancing and inhibitory effects of nitric oxide on superoxide anion generation in human polymorphonuclear leukocytes
233. Influence of nitric oxide on luminol-enhanced chemiluminescence measured from porcine-stimulated leukocytes
234. Effect of respiratory burst inhibitors on nitric oxide production by human neutrophils
235. Microbial killing by human neutrophil cytokineplasts: Similar suppressive effects of reversible inhibitors of nitric oxide synthase